News

Keep up to date with all the latest news from LTR Medical

News2019-11-25T13:31:29+10:00

PAnaesthesia Conference

November 15th, 2021|

On Saturday Danny Zanardo, VP Commercial and Anna Montgomery, Product Manager attended the PAnaesthesia Conference at the Princess Alexandra Hospital in Brisbane.  Being the first face-to-face conference in a very long time, it was a great opportunity to demonstrate new, game-changing devices that improve patient safety. SAFIRA is a groundbreaking new technology for regional anaesthesia.  It allows a single anaesthetist to conduct a whole regional block as a one operator procedure.  The SAFIRA improves patient safety by limiting the injection pressure to 20psi, thereby reducing the risk of nerve damage. TwitchView is a Train of Four Monitor that is like GPS for neuromuscular blocks.  Quantitative train of four monitoring eliminates the guesswork in the assessment of neuromuscular blockade.  Validated electromyography with TwitchView provides continuous measurements to inform clinical decisions and the TOF ratio needed to confirm patient recovery.  ANZCA PS18 Guideline on monitoring during anaesthesia (2017) states that quantitative neuromuscular [...]

LTR Medical receives TGA Approval for TwitchView™

September 2nd, 2021|

LTR Medical is excited to announce that it has recently gained TGA approval for Twitchview – an objective train-of-four (ToF) monitor for neuromuscular blockade and the first stand-alone EMG (electromyographic) based technology. TwitchView enables healthcare providers to deliver improved patient care and cost saving benefits by eliminating guesswork in the assessment of neuromuscular blocks, thereby improving patient recovery. With EMG Monitoring described as the gold standard for monitoring neuromuscular blockade, TwitchView has the potential to make a significant impact as the first stand-alone EMG based monitor available on the market. Danny Zanardo, VP Commercial LTR Medical, commented: “We believe the TwitchView is a vital addition to modern anaesthesia management and that it stands alone amongst train-of-four (ToF) monitors to safely improve patient recovery.  The team at LTR Medical are looking forward to launching TwitchView to Anaesthetists and patients in the Australian and New Zealand Markets.” Justin Hulvershorn, MD, PhD and [...]

LTR signs exclusive agreement to distribute TwitchView™ in Australia and New Zealand

July 15th, 2021|

LTR Medical has signed an agreement with Blink Device Company, an American based manufacturer to distribute TwitchView™ in the Australian and New Zealand markets. Blink Device Company, founded in Seattle by industry veterans, develops best in class technologies that address important patient safety concerns while reducing hospital costs. TwitchView is an objective train-of-four (TOF) monitor for neuromuscular blockade and the first stand-alone EMG (electromyographic) based technology. With EMG monitoring described as the gold standard for monitoring neuromuscular blockade, TwitchView™ has the potential to make a significant impact. Preceeded by a successful United States launch, this distribution agreement to bring TwitchView to market in Australia and New Zealand marks a significant further step in making this new medical technology available to healthcare providers to help deliver improved patient care and cost saving benefits. Danny Zanardo, VP Commercial LTR Medical, commented: “The team at LTR Medical are excited to partner with Blink [...]

Introducing SAFIRA™ to Veterinary Practice

July 14th, 2021|

LTR Medical and Medovate, the manufacturer of SAFIRA™ have signed an agreement which will allow us to assess the potential for distribution of SAFIRA™ for veterinary use across Australia and New Zealand. SAFIRA™ - a revolutionary new technology that transforms regional anaesthesia into a one-person procedure - was originally developed for human patient use in hospitals, but there is huge potential for its unique benefits to be extended to veterinary regional anaesthesia. Over the coming months we will work to engage with veterinary practices to secure evaluations of SAFIRA™ for veterinary applications. The studies will complement the UK studies that are already underway providing further insights and evidence of the potential for SAFIRA™ in small animal anaesthesia. SAFIRA™ incorporates a unique safety solution that limits injection pressure, helping to reduce the risk of nerve injury. In current regional anaesthesia procedures, two operators are often needed, including a second operator [...]

Dr Minh Tran

May 17th, 2021|

Watch this great video with Dr Minh Tran discussing his experiencing using the SAFIRA™ in practice. Medovate talked with Dr Minh T. Tran after he had successfully used SAFIRA™ with a number of patients undergoing regional anaesthesia. Watch here: https://bit.ly/2REHUbo Dr Tran is based in Sydney and it was great to hear his positive feedback on his experience of using the device for upper limb blocks, as well as hip and knee surgeries. Watch the short video to hear Dr Tran's thoughts on the autonomy SAFIRA™ gives anaesthetists, as well as the consistency of injection pressure. As the Australian and New Zealand distributor for SAFIRA™, LTR Medical are available to help any regional anaesthetists who would like to see the benefits of this exciting technology for themselves. For further information, call 1800 319 419 or visit our product page SAFIRA™ SAFIRA™: SAFer Injection for Regional Anaesthesia Creates a single operator procedure Engineered [...]

SAFIRA™

February 25th, 2021|

Another satisfied Anaesthetist evaluating the SAFIRA – SAFer Injection for Regional Anaesthesia.  Providing safer and easier Regional Anaesthesia. For more information  call us on 1800 319 419 or visit our product page SAFIRA™  

Call us Now

Call us for more information on our products on 1800 319 419.

Go to Top